WNRC Wenr Corporation (CE)

St. Paul Pharmaceutical, a pending merger partner with WENR Corp. (OTC:WNRC) (wenr.net), announced today that it signed a distribution agreement with Akzo Nobel of the Netherlands to distribute Ferrazone(R) to countries in southeast Asia. St. Paul's agreement includes the distribution of Ferrazone(R) in Viet Nam, Cambodia and Laos with a potential market of over 100 million people. Ferrazone(R) is Akzo Nobel's brand name for sodium iron (III) ethylenediaminetetraacetate (NaFeEDTA). It is also commonly known as sodium feredetate. Ferrazone(R) is an additive for food products including rice, coffee, tea and milk. UNICEF estimates that iron deficiency affects half of the developing world's infants, undermines the health of 500 million women of reproductive age and leads to more than 60,000 childbirth deaths a year. It also causes a range of other problems in millions of people, such as impaired cognitive development in children, exhausting fatigue, maternal mortality and low productivity in the workplace. Traditionally, one of the most effective ways to combat any deficiency has been to add supplements to staple foods, something that has been done in Western countries for the last half a century. St. Paul Pharmaceutical is a manufacturer and distributor of pharmaceuticals with locations in Viet Nam, Canada and California. Recently the Company has signed a letter of intent to merge with WENR Corp. WENR Corporation is a holding company that acquires technology and technology companies. It provides senior management assistance for product and market development and secures working capital. The foregoing contains forward-looking information within the meaning of The Private Securities Litigation Act of 1995. Such forward-looking statements involve certain risks and uncertainties. The actual results may differ materially from such forward-looking statements. The company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results (expressed or implied) will not be realized.